Q91.5 Trisomy 13, mosaicism (mitotic nondisjunction)

Name of the Condition

• Trisomy 13, mosaicism (mitotic nondisjunction)

Summary

Trisomy 13, mosaicism (mitotic nondisjunction) is a chromosomal condition where some cells in the body have an extra copy of chromosome 13, while others have the typical two copies. This occurs due to errors in cell division after fertilization. The presence of both normal and abnormal cells can lead to a range of physical and developmental differences, which may be less severe than in full trisomy 13, depending on the proportion and distribution of affected cells.

Causes

This condition results from mitotic nondisjunction, an error in cell division that happens after fertilization. During early embryonic development, a cell fails to separate chromosome 13 properly, creating a cell line with three copies (trisomy) alongside normal cells with two copies. The specific triggers for this error are not always identifiable, but it is not inherited from parents in most cases.

Risk Factors

• Advanced maternal age, as the risk of chromosomal errors increases with age.
• No known modifiable risk factors, as the error occurs randomly during cell division.

Symptoms

• Variable physical features, which may include heart defects, growth delays, and distinct facial characteristics.
• Developmental delays, with severity depending on the proportion of affected cells.
• Possible organ abnormalities (e.g., brain, kidney, or abdominal defects).
• Distinctive facial features (e.g., microphthalmia, cleft lip/palate, or scalp defects).

Diagnosis

Prenatal diagnosis may involve ultrasound, amniocentesis, or chorionic villus sampling (CVS) to detect chromosomal abnormalities. Postnatal confirmation is achieved through karyotyping or chromosomal microarray analysis, which can identify the mosaic pattern of affected cells.

Treatment Options

Management focuses on supportive care, including addressing specific organ defects (e.g., cardiac or surgical interventions), nutritional support, and developmental therapies. Care is tailored to the individual’s symptoms and needs.

Prognosis and Follow-Up

Prognosis varies based on the extent of chromosomal mosaicism and associated anomalies. Some individuals may have a longer lifespan than those with full trisomy 13, but life expectancy remains limited. Regular follow-up with specialists (e.g., geneticists, cardiologists) is essential to monitor health and address complications.

Complications

• Severe congenital anomalies (e.g., heart defects, brain malformations).
• Respiratory or feeding difficulties.
• Increased risk of infections due to weakened immune function.
• Developmental delays or intellectual disabilities.

Lifestyle & Prevention

No specific lifestyle changes can prevent this condition, as it arises from random cellular errors. Genetic counseling may be recommended for families to discuss recurrence risks and future pregnancies.

When to Seek Professional Help

Seek medical attention if prenatal screening suggests chromosomal abnormalities, or if an infant exhibits symptoms such as poor feeding, abnormal facial features, or organ-related issues. Early diagnosis and intervention can improve outcomes.

Tips for Medical Coders

Use code Q91.5 for Trisomy 13, mosaicism (mitotic nondisjunction). Document the presence of mosaicism (e.g., via karyotype results) and specify if it is mitotic nondisjunction. Ensure clinical documentation supports the diagnosis to justify coding accuracy.